Results 241 to 250 of about 325,167 (345)

Glial fibrillary acidic protein antibody-associated astrocytopathy presents isolated spinal cord enhancement: A case report. [PDF]

Medicine (Baltimore)
Wang C, Zou X, Du X, Xue Y, Bao W, Guo Y.   +5 more
europepmc   +1 more source

Some Spinal Cord Lesions: VII. Hereditary Ataxy (Friedreich's Disease).

, 1911

openalex   +1 more source

Cuneiform Nucleus Stimulation Can Assist Gait Training to Promote Locomotor Recovery in Individuals With Incomplete Tetraplegia

Annals of Neurology, EarlyView.
Objective Impaired ability to induce stepping after incomplete spinal cord injury (SCI) can limit the efficacy of locomotor training, often leaving patients wheelchair‐bound. The cuneiform nucleus (CNF), a key mesencephalic locomotor control center, modulates the activity of spinal locomotor centers via the reticulospinal tract.
Anna‐Sophie Hofer, Lennart H. Stieglitz, Marc Bolliger, Linard Filli, Adrian Cathomen, Romina Willi, Irina Lerch, Iris Krüsi, Melina Giagiozis, Christian Meyer, Martin Schubert, Michèle Hubli, Thomas M. Kessler, László Demkó, Christian R. Baumann, Lukas Imbach, Markus F. Oertel, Andrea Prusse, Alina Kiseleva, Luca Regli, Martin E. Schwab, Armin Curt   +21 more
wiley   +1 more source

Spinal cord vascular autoregulation: key concepts and opportunities to improve management. [PDF]

Spinal Cord
Routkevitch D, Jiang K, Weber-Levine C, Davidar AD, Thakor NV, Mintz CD, Rosenblatt K, Geocadin RG, Theodore N.   +8 more
europepmc   +1 more source

From Diagnosis to Disease Staging: Multisite Validation of Cerebrospinal Fluid Molecular Tests in Multiple Sclerosis

Annals of Neurology, EarlyView.
Objective The growing demand for personalized treatment in multiple sclerosis (MS) highlights the need for more precise biomarkers that can outperform magnetic resonance imaging and clinical assessment in patient stratification. Advances in multiplex proteomic technologies suggest that cerebrospinal fluid (CSF) analysis at MS onset may not only improve
Laura Ghezzi, Peter Kosa, Mark Greenwood, Enrique Alvarez, C.L. Freedman, Anne H. Cross, Francesca Pace, Mark S. Freedman, Joanna Kocot, Laura Piccio, Bibiana Bielekova   +10 more
wiley   +1 more source

AAV9 gene therapy optimization for SMARD1/CMT2S: safety and long-term efficacy comparison of two vectors in a SMARD1 preclinical model. [PDF]

J Biomed Sci
Pagliari E, Anastasia A, Bellandi F, Garbellini M, Ongaro J, Taiana M, Comi GP, Ottoboni L, Sierra-Delgado JA, Likhite S, Meyer KC, Nizzardo M, Corti SP.   +12 more
europepmc   +1 more source

Recombinant Human Neuregulin1‐β1 Significantly Reduces Schwannoma Growth in Mice

Annals of Neurology, EarlyView.
rhNRGβ1‐Replacement‐Therapy: Under physiological conditions, NRGβ1 is expressed on axons (in orange), where it activates ERBB2 receptors, facilitating successful nerve regeneration following injury. However, loss of NF2 leads to a reduction in NRGβ1‐expression and increased ErbB2 levels on Schwann cells (in green), which contributes to schwannoma ...
Julia P. Bischoff, Alexander Schulz, Christian Hagel, Robert Büttner, Michael Reuter, Waylan K. Bessler, D. Wade Clapp, Helen Morrison   +7 more
wiley   +1 more source

Monitoring morphometric drift in lifelong learning segmentation of the spinal cord. [PDF]

Imaging Neurosci (Camb)
Naga Karthik E, Bédard S, Valošek J, Aigner CS, Bannier E, Bednařík J, Callot V, Combes A, Curt A, David G, Eippert F, Farner L, Fehlings MG, Freund P, Granberg T, Granziera C, Horn U, Horák T, Humphreys S, Hupp M, Kerbrat A, Kinany N, Kolind S, Kudlička P, Lebret A, Lee LE, Mainero C, Martin AR, McGrath M, Nair G, O'Grady KP, Oh J, Ouellette R, Pfender N, Pfyffer D, Pradat PF, Prat A, Pravatà E, Reich DS, Ricchi I, Rotem-Kohavi N, Schading-Sassenhausen S, Seif M, Smith A, Smith SA, Sweeney G, Tam R, Traboulsee A, Treaba CA, Tsagkas C, Vavasour Z, Van De Ville D, Weber Ii KA, Chandar S, Cohen-Adad J.   +54 more
europepmc   +1 more source

Combination of Serum Neurofilament Light Chain and Serum Cardiac Troponin T as Biomarkers Improves Diagnostic Accuracy in Amyotrophic Lateral Sclerosis

Annals of Neurology, EarlyView.
Objective We aimed to evaluate the clinical utility of serum neurofilament light chain (sNfL) and cardiac troponin T (cTnT) in amyotrophic lateral sclerosis (ALS) and assess whether their combination improves diagnostic accuracy. Methods We retrospectively analyzed 293 ALS patients, 85 neurodegenerative disease controls, and 29 healthy controls.
Paula Lindenborn, Rachel Fabian, Torsten Grehl, Huelya Nazlican, Thomas Meyer, Sarah Bernsen, Patrick Weydt   +6 more
wiley   +1 more source

Pharmacological Inhibition of EZH2 by GSK-343 Attenuates Neuroinflammation in a Mouse Model of Spinal Cord Injury. [PDF]

J Neurosci Res
Kang Y, Mannino D, Bova V, Repici A, Maria B, Hasan A, Catalfamo A, Yang J, Lanza M, Filippone A.   +9 more
europepmc   +1 more source